KalVista Pharmaceuticals, Inc. (FRA:4XC1)
Germany · Delayed Price · Currency is EUR 13.50
+0.90 (7.14%)
At close: Jan 2, 2026
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of €730.04 million as of January 9, 2026. Its market cap has increased by 73.95% in one year.
Market Cap
730.04M
Enterprise Value
707.19M
Revenue
1.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
€13.50
Market Cap Chart
Since November 23, 2016, KalVista Pharmaceuticals's market cap has increased from 78.86M to 730.04M, an increase of 825.78%. That is a compound annual growth rate of 27.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 730.04M | 5.00% |
| Dec 31, 2025 | 695.26M | 71.97% |
| Dec 31, 2024 | 404.30M | 5.56% |
| Dec 29, 2023 | 383.00M | 77.55% |
| Dec 30, 2022 | 215.71M | -24.22% |
| Dec 31, 2021 | 284.66M | 2.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |